These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 10779384)

  • 1. Analysis of a mutation in phosphodiesterase type 4 that alters both inhibitor activity and nucleotide selectivity.
    Herman SB; Juilfs DM; Fauman EB; Juneau P; Menetski JP
    Mol Pharmacol; 2000 May; 57(5):991-9. PubMed ID: 10779384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of substrate specificity determinants in human cAMP-specific phosphodiesterase 4A by single-point mutagenesis.
    Richter W; Unciuleac L; Hermsdorf T; Kronbach T; Dettmer D
    Cell Signal; 2001 Mar; 13(3):159-67. PubMed ID: 11282454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of PDE8A, a novel human cAMP-specific phosphodiesterase.
    Fisher DA; Smith JF; Pillar JS; St Denis SH; Cheng JB
    Biochem Biophys Res Commun; 1998 May; 246(3):570-7. PubMed ID: 9618252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of phosphodiesterase 4 in guinea-pig macrophages: multiple activities, association states and sensitivity to selective inhibitors.
    Kelly JJ; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1998 May; 124(1):129-40. PubMed ID: 9630352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells.
    Verghese MW; McConnell RT; Lenhard JM; Hamacher L; Jin SL
    Mol Pharmacol; 1995 Jun; 47(6):1164-71. PubMed ID: 7603456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation and induction of cyclic AMP phosphodiesterase (PDE4) in rat pulmonary microvascular endothelial cells.
    Zhu B; Kelly J; Vemavarapu L; Thompson WJ; Strada SJ
    Biochem Pharmacol; 2004 Aug; 68(3):479-91. PubMed ID: 15242814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structures of the catalytic domain of phosphodiesterase 4B complexed with AMP, 8-Br-AMP, and rolipram.
    Xu RX; Rocque WJ; Lambert MH; Vanderwall DE; Luther MA; Nolte RT
    J Mol Biol; 2004 Mar; 337(2):355-65. PubMed ID: 15003452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TcPDE4, a novel membrane-associated cAMP-specific phosphodiesterase from Trypanosoma cruzi.
    Alonso GD; Schoijet AC; Torres HN; Flawiá MM
    Mol Biochem Parasitol; 2006 Jan; 145(1):40-9. PubMed ID: 16225937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of PDE4 structure on inhibitor selectivity across PDE families.
    Ke H
    Int J Impot Res; 2004 Jun; 16 Suppl 1():S24-7. PubMed ID: 15224132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long PDE4 cAMP specific phosphodiesterases are activated by protein kinase A-mediated phosphorylation of a single serine residue in Upstream Conserved Region 1 (UCR1).
    MacKenzie SJ; Baillie GS; McPhee I; MacKenzie C; Seamons R; McSorley T; Millen J; Beard MB; van Heeke G; Houslay MD
    Br J Pharmacol; 2002 Jun; 136(3):421-33. PubMed ID: 12023945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial characterization of the active site human platelet cAMP phosphodiesterase, PDE3A, by site-directed mutagenesis.
    Cheung PP; Yu L; Zhang H; Colman RW
    Arch Biochem Biophys; 1998 Dec; 360(1):99-104. PubMed ID: 9826434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PDE4B5, a novel, super-short, brain-specific cAMP phosphodiesterase-4 variant whose isoform-specifying N-terminal region is identical to that of cAMP phosphodiesterase-4D6 (PDE4D6).
    Cheung YF; Kan Z; Garrett-Engele P; Gall I; Murdoch H; Baillie GS; Camargo LM; Johnson JM; Houslay MD; Castle JC
    J Pharmacol Exp Ther; 2007 Aug; 322(2):600-9. PubMed ID: 17519386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A reporter gene assay for screening of PDE4 subtype selective inhibitors.
    Bora RS; Malik R; Arya R; Gupta D; Singh V; Aggarwal N; Dastidar S; Ray A; Saini KS
    Biochem Biophys Res Commun; 2007 Apr; 356(1):153-8. PubMed ID: 17336928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential type 4 cAMP-specific phosphodiesterase (PDE4) expression and functional sensitivity to PDE4 inhibitors among rats, monkeys and humans.
    Bian H; Zhang J; Wu P; Varty LA; Jia Y; Mayhood T; Hey JA; Wang P
    Biochem Pharmacol; 2004 Dec; 68(11):2229-36. PubMed ID: 15498513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and characterization of deletion recombinants of two cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE-3).
    He R; Komas N; Ekholm D; Murata T; Taira M; Hockman S; Degerman E; Manganiello VC
    Cell Biochem Biophys; 1998; 29(1-2):89-111. PubMed ID: 9631240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of inhibitor binding sites of the cAMP-specific phosphodiesterase 4.
    Richter W; Unciuleac L; Hermsdorf T; Kronbach T; Dettmer D
    Cell Signal; 2001 Apr; 13(4):287-97. PubMed ID: 11306246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Rv0805 gene from Mycobacterium tuberculosis encodes a 3',5'-cyclic nucleotide phosphodiesterase: biochemical and mutational analysis.
    Shenoy AR; Sreenath N; Podobnik M; Kovacevic M; Visweswariah SS
    Biochemistry; 2005 Dec; 44(48):15695-704. PubMed ID: 16313172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural determinants for inhibitor specificity and selectivity in PDE2A using the wheat germ in vitro translation system.
    Iffland A; Kohls D; Low S; Luan J; Zhang Y; Kothe M; Cao Q; Kamath AV; Ding YH; Ellenberger T
    Biochemistry; 2005 Jun; 44(23):8312-25. PubMed ID: 15938621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning and characterization of the human and mouse PDE7B, a novel cAMP-specific cyclic nucleotide phosphodiesterase.
    Gardner C; Robas N; Cawkill D; Fidock M
    Biochem Biophys Res Commun; 2000 May; 272(1):186-92. PubMed ID: 10872825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cells.
    Growcott EJ; Spink KG; Ren X; Afzal S; Banner KH; Wharton J
    Respir Res; 2006 Jan; 7(1):9. PubMed ID: 16423283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.